Skip to main content

Botanix’s Sofdra hits the market

1 day ago

Bookmark

Save articles for future reference.

ASX-listed Botanix has shipped the first batch of Sofdra prescriptions, marking a milestone moment as it shifts towards becoming a revenue generating pharmaceuticals company.

X

To read our articles you will need to either login or subscribe.